These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16777405)

  • 1. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging patients with myeloma.
    Winterbottom AP; Shaw AS
    Clin Radiol; 2009 Jan; 64(1):1-11. PubMed ID: 19070692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA; Nguyen BD
    Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma update.
    Mulligan ME
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imaging methods in diagnosis and monitoring of multiple myeloma].
    Myslivecek M; Nekula J; Bacovský J
    Vnitr Lek; 2006 Nov; 52 Suppl 2():46-54. PubMed ID: 18175429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
    Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
    Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
    Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
    Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern imaging of multiple myeloma.
    Seppanen M
    Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
    Truong MT; Munden RF; Movsas B
    J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
    Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
    Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL; Jones RJ; Wahl RL
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.